Nonclinical precedent Request an invite

Zalmoxis: which tox species, and why?

allogeneic T cells modified with HSV-TK / dLNGFR (nalotimagene carmaleucel) · HSV-TK suicide-gene T cells
Species
Immunodeficient NOD/SCID mice (GvHD xenograft models); no conventional tox species
“Two studies in two different GvHD animal models both based on the NOD/SCID system were performed to evaluate the PK and primary PD of MM-TK.”
✓ VerifiedEMA assessment report, p. 24Source ↗
Why that species
Product is species specific; NOD/SCID mice permit human T cell engraftment and GvHD readout
“The MM-TK DP is a species specific product and therefore standard carcinogenicity studies using rodents or non-human primates as described in the ICH guidelines are not appropriate.”
✓ VerifiedEMA assessment report, p. 22Source ↗
Surrogate molecule
No surrogate; human MM-TK cells in NOD/SCID mice (one model with grafted human skin)
“NOD/SCID mice subcutaneously transplanted with human skin were also used so that the direct evaluation of allogeneic GvHD response against the grafted human skin could be observed.”
✓ VerifiedEMA assessment report, p. 17Source ↗
Species: general tox
No repeat-dose studies; toxicity assessed within two NOD/SCID mouse GvHD models (integrated PD/PK/tox)
“To evaluate safety and functional properties of MM-TK, the Applicant developed an integrated approach which included both in vivo pharmacodynamic, toxicology and kinetic data concurrently obtained taking advantage of two different immunodeficient mouse models for Graft versus Host Disease (GvHD) based on the Non-Obese Diabetes/Severe Compromised Immunodeficient (NOD/SCID) mouse system”
✓ VerifiedEMA assessment report, p. 20Source ↗
Species: DART
Not conducted; absence considered justified
“The lack of studies on reproductive and development toxicity is justified.”
✓ VerifiedEMA assessment report, p. 26Source ↗
Species: carcinogenicity
Not conducted (species-specific product; rodent/NHP carcinogenicity studies not appropriate)
“The MM-TK DP is a species specific product and therefore standard carcinogenicity studies using rodents or non-human primates as described in the ICH guidelines are not appropriate.”
✓ VerifiedEMA assessment report, p. 22Source ↗
Surrogate used in
No surrogate used; the human MM-TK product (original and optimized vector) was tested in immunodeficient mice
“Preclinical in vitro and in vivo studies in immune deficient mice were performed using for cell preparation both the SFCMM-3 #35 retroviral vector and an optimized version of the vector”
✓ VerifiedEMA assessment report, p. 17Source ↗

Same question, other cell therapies

Abecma

idecabtagene vicleucel · BCMA CAR-T
No relevant species; NSG mouse xenografts and in vitro only

Alofisel

darvadstrocel · Allogeneic adipose MSC
Immunocompromised athymic nude rats (GLP); nude mice for tumourigenicity

Amtagvi

lifileucel · TIL therapy
No animal studies with product; published murine and human TIL literature only

Aucatzyl

obecabtagene autoleucel · CD19 CAR-T
No relevant species; no in vivo tox. NSG xenograft (pharmacology) and human tissue cross-reactivity only

Breyanzi

lisocabtagene maraleucel · CD19 CAR-T
No relevant species; in vitro and NSG mouse xenograft only

Carvykti

ciltacabtagene autoleucel · BCMA CAR-T
No relevant species; NCG mouse xenografts, non-GLP NHP pilot with autologous NHP CAR-T

ChondroCelect

characterised viable autologous cartilage cells · Autologous chondrocytes
Nude mouse (ectopic), sheep and goat (orthotopic); non-GLP combined PD/PK/tox

Ebvallo

tabelecleucel · EBV-specific allogeneic T cells
SCID mice (EBV+ lymphoma xenograft, literature/PD); no tox species

Encelto

revakinagene taroretcel · CNTF (encapsulated RPE cell implant)
Minipig, pig and rabbit (ocular tox/PK); rcd1 dog for pharmacology; rat and rabbit for rhCNTF DART

Gintuit

allogeneic cultured keratinocytes and fibroblasts in bovine collagen · Allogeneic keratinocytes + fibroblasts
Athymic (nude) mice for pharmacology; rabbits, guinea pigs, mice for biocompatibility

Holoclar

autologous corneal epithelial cells containing limbal stem cells · Autologous limbal stem cells
No animal species; abridged programme of in vitro tumorigenicity assays and literature

Kymriah

tisagenlecleucel · CD19 CAR-T
No relevant species; immunodeficient mouse B-ALL xenograft (non-GLP) only

Lantidra

donislecel · Allogeneic pancreatic islets
No studies with product; literature only (diabetic mice, rats, NHP, pigs)

Laviv

azficel-T · Autologous fibroblasts
No preclinical or toxicology studies conducted with the product

MACI

autologous cultured chondrocytes on porcine collagen membrane · Autologous chondrocytes
Rabbit and horse, with analogous MACI (species-matched autologous cells on ACI-Maix)

Omisirge

omidubicel · Expanded cord blood HPC
Immunodeficient irradiated NOD/SCID mouse only (xenogeneic human cells)

Provenge

sipuleucel-T · PAP-GM-CSF (autologous APC)
No conventional tox species; rat and mouse proof-of-concept studies with rodent surrogate products

Rethymic

allogeneic processed thymus tissue · Allogeneic thymus tissue
No relevant species; nude rat pharmacology studies only, no tox

Ryoncil

remestemcel-L · Allogeneic BM-MSC
Rat, baboon and pig using species-specific surrogate ceMSC

Spherox

spheroids of autologous matrix-associated chondrocytes · Autologous chondrocyte spheroids
Immunodeficient (SCID/NSG) mice, Goettingen minipig, Merino sheep; no conventional tox

StrataGraft

allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen · Allogeneic keratinocytes + fibroblasts
Athymic nude mice only (immunodeficient wound model)

Tecartus

brexucabtagene autoleucel · CD19 CAR-T
No relevant species; in vitro and syngeneic mouse surrogate CAR-T only

Tecelra

afamitresgene autoleucel · MAGE-A4 TCR-T
No relevant species; in vitro cross-reactivity/alloreactivity and murine xenograft pharmacology only

Tregzi

allogeneic Treg immunotherapy with HSPC and T cells (Orca-T) · Allogeneic Treg + HSPC + Tcon
No tox species; sublethally irradiated immunodeficient mice (xenogeneic GVHD proof-of-concept) plus published murine literature

Yescarta

axicabtagene ciloleucel · CD19 CAR-T
No relevant species; syngeneic mouse lymphoma model with murine surrogate CAR-T (published, non-GLP)

Zemcelpro

dorocubicel · UM171-expanded cord blood CD34+
Female sub-lethally irradiated NSG mice (human cells); UM171 compound PK/tox in NSG mouse, rat, cynomolgus monkey

Summary across all 27 cell therapies →